-
Recent Posts
- We’ve Moved! Continue following the WatchBlog at GAO.gov/blog
- What is the Consumer Product Safety Commission, and How Does It Protect Consumers from Hazards?
- The 2021 High Risk List—Which Programs Are At High Risk of Fraud, Waste, and Abuse? (videos)
- Pregnant Women in Federal Custody—A Uniquely Vulnerable Population
- Medicaid in Times of Crisis, and An Introduction to Our New Special Product—The Health Care Capsules
- U.S. Spending on Afghanistan Reconstruction at Risk of Fraud, Waste, and Abuse
- How the Small Business Administration Partners with Historically Black Colleges and Universities
- Rural Hospital Closures Create More Distance Between Residents and Care
- Vaccine Distribution, Supply Chain, Testing Still Present Challenges in Federal Pandemic Response
- Move Over! How Are Governments Trying to Protect First Responders From Roadside Crashes? (video)
Categories
- About GAO
- Agriculture and Food
- Auditing and Financial Management
- Budget and Spending
- Business Regulation and Consumer Protection
- Collections
- Communications
- Coronavirus
- disaster assistance
- Disaster Assistance
- Duplication and Cost Savings
- Economic Development
- Education
- Employment
- Energy
- Equal Opportunity
- Financial Markets and Institutions
- Fiscal Outlook and The Debt
- Fraud
- Government Operations
- Graphic
- Health Care
- High Risk List
- Homeland Security
- Housing
- Human Capital
- Infographic
- Information Management
- Information Security
- Information Technology
- Interactive graphic
- International Affairs
- Justice and Law Enforcement
- Key Issues
- Mission Team
- National Defense
- Natural Resources and Environment
- OGC
- Podcast
- Quick Look
- Racial Disparities
- Recovery Act
- Retirement Security
- Science and Technology
- Space
- Tax Policy and Administration
- Technology Assessment
- Topics
- Trade
- Transportation
- Veterans
- Video
- Worker and Family Assistance
Tag Archives: Vaccine development
COVID-19 Vaccines and the Lessons Learned from H1N1
As the federal government responds to the coronavirus pandemic, we here at GAO have been monitoring the response efforts—including reviewing COVID-19 vaccine development and authorization. Today’s WatchBlog explores our past work on vaccine distribution and lessons learned from the H1N1 … Continue reading
